Medoflucon

Fluconazole, the active ingredient in Medoflucon, is an azole antifungal presented as an oral tablet for systemic use. It treats a range of fungal infections, including candidiasis, cryptococcal meningitis, dermatophyte infections and other systemic mycoses, and is prescribed for both adult and pediatric patients when indicated.

GNH USA supplies Medoflucon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance through validated manufacturing processes.

Fluconazole is used to treat fungal infections by targeting yeasts and molds in various clinical settings.

Candidiasis: Effective for oral, esophageal and vaginal yeast infections, reducing fungal burden and symptom severity. Cryptococcal meningitis: Provides systemic antifungal activity to clear central nervous system infection. Dermatophyte infections: Treats skin and nail fungal infections by inhibiting fungal growth. Systemic fungal infections: Used for invasive mycoses such as candidemia and other deep-seated infections.

Adverse reactions may occur with fluconazole therapy.

Common Side Effects: - Nausea or vomiting - Headache - Abdominal discomfort or diarrhea - Rash or mild skin irritation - Elevated liver enzymes detected in laboratory tests

Serious or Rare Side Effects: - Hepatotoxicity, including severe liver injury - Severe cutaneous reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis - Anaphylactic or severe allergic reactions - QT interval prolongation leading to cardiac arrhythmias - Hematologic abnormalities such as neutropenia

Use of Medoflucon requires careful clinical assessment and monitoring. - Renal impairment: dose may need adjustment and renal function should be monitored. - Hepatic disease: monitor liver function tests before and during therapy. - Pregnancy: risk category is unknown; weigh potential benefits against possible fetal risks. - Concomitant medications: review for potential drug interactions before initiating therapy. - Known hypersensitivity to azole antifungals: avoid use in patients with documented allergy. - Store at room temperature: keep in the original container, protect from moisture and light.

Fluconazole can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Rifampin: induces metabolism, markedly reducing fluconazole plasma levels. - Co‑administration with other azole antifungals: may increase risk of toxicity. - Terbinafine: combined use raises the potential for hepatotoxicity. - Certain protease inhibitors (e.g., ritonavir): can increase fluconazole concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: fluconazole may increase INR; monitor coagulation parameters. - Phenytoin: may enhance fluconazole metabolism, reducing its effectiveness. - Oral hypoglycemic agents: fluconazole can potentiate glucose‑lowering effects; monitor blood sugar levels.